Could S-100b be a marker of the neurologic involvement in HIV-affected patients?

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 4, 2006, Pages 939-942

  Dalessandro, M ^a   Petrarca, C ^a   Falasca, K ^a   Lattanzio, F M ^a   Zingariello, P ^a   Manzoli, L ^b   Racciatti, D ^a   Fulvi, S ^a   Toniato, E ^b   Pizzigallo, E ^a   Martinotti, S ^a   Vecchiet, Jacopo ^a,b  

^a Policlinico SS Annunziata   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

HIV; Neurologic complications; Neurologic markers; S 100b protein

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN S100B; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 33846444734     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900426     Document Type: Letter

References (10)

1. Orandle M.S., A.G. MacLean, V.G. Sasseville, X. Alvarez and A.A. Lackner. 2002. Enhanced expression of proinflammatory cytokines in the central nervous system by simian immunodeficiency virus and the development of encephalitis. J. Virol. 76:5797.
2. Vecchiet J., M. Dalessandro, K. Falasca, A. Di Iorio, F. Travasi, P. Zingariello, C. Schiavone, F. Ensoli, E. Pizzigallo and R. Paganelli. 2003. Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. J. Acquir. Immune Deficienc. Syndr. 32:464.
3. Mrak R.E. and W.S. Griffinbc. 2001. The role of activated astrocytes and of the neurotrophic cytokine SlOOb in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 22:915.
4. Infante J.R., A. Martinez, J. Ochoa, F. Canadillas, M. Torres-Avisbal, J. A. Vallejo, F.M. Gonzales, C. Pacheco and J.M. Latre. 2003. Cerebrospinal fluid S-100 protein levels in neurological pathologies. J. Physiol. Biochem. 59:255.
5. Raabe A., O. Kopetsch, A. Woszczyk, J. Lang, R. Gerlach, M. Zimmermann and V. Seifert. 2003. Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor. Neurol. Neurosci. 21:159.
6. Pemberton L.A. and B.J. Brew. 2001. Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. J. Clin. Virol. 22:249.
7. Corasiniti M.T., D. Rotiroti, G. Nappi and G. Bagetta. 2003. Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS. Toxicol. Lett. 139:199.
8. Fagnart O.C., C.J. Sindk and C. Laterrec. 1988. Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin. Chem. 34:1387.
9. Green A.J., G. Giovannoni, M.A. Hall-Craggs, E.J. Thompson and R.F. Miller. 1999. Cerebrospinal fluid S-100b concentrations in patients with HIV infection. AIDS 13:139.
10. Vecchiet J., M. Dalessandro, F. Travasi, K. Falasca, A. Di Iorio, C. Schiavone, P. Zingariello, E. Di Ilio and E. Pizzigallo. 2003. Interleukin-4 and Interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol. 16:33.